Kaynak: Zacks Investment Research Haber Ajansı
1 ay önce•
Hisse Senedi Orta Önem
MRK Q2 Earnings & Sales Beat Estimates, '26 Sales View Raised

MRK Q2 Earnings & Sales Beat Estimates, '26 Sales View Raised

Merck beat Q2 earnings and sales estimates as strong oncology and newer products lift results, prompting the company to raise and narrow its 2026 sales outlook.
İlgili Semboller 1
MRK MRK
Kaynak: Zacks Investment Research
Kaynağı Ziyaret Et
0 0 0
Yorum Yap
Yorumlar
0
Henüz yorum yok
Bu habere ilk yorum yapan kişi olun.